Cutler Group LP Kura Oncology, Inc. Put Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Put Options
1 transactions
Others Institutions Holding KURA
# of Institutions
195Shares Held
80MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$81.1 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$77.5 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$69.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$61.9 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$53.4 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $668M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...